News + Media

November 23, 2021

A Conversation with Our ADDF-Harrington Scholars: Studying Drug Candidates to Restore Brain Function in Alzheimer's Patients

Earlier this year, two outstanding researchers, Paul Fish, Ph.D., of University College London’s Drug Discovery Institute and Paul Worley, M.D., of Johns Hopkins University, were selected by the Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals in Cleveland to... Continue Reading

August 19, 2021

Oxford-Harrington Partnership Targets FA as First Priority

Scientists on either side of the Atlantic have teamed up, through the new Oxford-Harrington Rare Disease Centre (OHC), to address unmet needs in rare disease research and deliver “major clinical impact” to patients. And now, the international collaboration between the University of Oxford, in England, and the... Continue Reading

July 01, 2021

The Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute to Support Promising Research to Restore Brain Function in People with Alzheimer’s Disease

Dr. Paul Fish of University College London and Dr. Paul Worley of Johns Hopkins University selected for their work aimed at restoring brain function NEW YORK, NY – The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals in Cleveland have granted ADDF-Harrington... Continue Reading

March 02, 2021

Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Invite Proposals for 2021 ADDF-Harrington Scholar Award

The 2021 award targets epigenetics, proteostasis and other novel approaches Cleveland, Ohio – Harrington Discovery Institute at University Hospitals and the Alzheimer's Drug Discovery Foundation (ADDF) announce a joint request for proposals for the 2021 ADDF-Harrington Scholar Award. The ADDF-Harrington Scholar Award is... Continue Reading

October 14, 2020

Harrington Discovery Institute Announces Award Recipients in New UK Rare Disease Program

Five scientists selected for their breakthrough discoveries with the potential to advance to clinical trials October 14, 2020, CLEVELAND, Ohio USA – The Harrington Discovery Institute® at University Hospitals in Cleveland, Ohio, and its registered charity Fund for Cures UK, Ltd., together with Morgan Stanley GIFT... Continue Reading

June 11, 2020

Harrington Discovery Institute Announces Award Recipients in its COVID-19 Rapid Response Initiative

Call for proposals yields one of world’s largest COVID-19 portfolios June 11, 2020, CLEVELAND, Ohio USA – The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, in collaboration with Morgan Stanley GIFT (Global Impact Funding Trust) Cures, today announced 12 award winners in the COVID-19... Continue Reading

April 07, 2020

Harrington Discovery Institute Issues Transatlantic Call for Proposals to Treat Coronavirus and its Clinical Impact

Philanthropic drug development program seeks to accelerate treatments into human clinical trials April 7, 2020, CLEVELAND, Ohio USA - The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today issued a transatlantic call for proposals for new treatments, pursuant to its recently announced major... Continue Reading

January 27, 2020

Harrington Discovery Institute Invites Proposals for 2020 Harrington UK Rare Disease Scholar Award

New grant program seeks to advance therapies for rare diseases January 27, 2020, Cleveland, Ohio – The Harrington Discovery Institute® at University Hospitals in Cleveland, Ohio, and its registered UK charity Fund for Cures UK, Ltd. (Fund for Cures UK) have issued a call for proposals for the 2020 Harrington UK Rare... Continue Reading

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.

Necessary

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. These cookies do not store any personal information.

Non-Necessary

We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. It is mandatory to procure user consent prior to running these cookies on your website.

Sign Up

Become a part of our community and receive periodic communications with news and updates, as well as notifications of grant funding opportunities.